Home
Drugs
Atezolizumab
Clinical Trials

Clinical Trials Related to Atezolizumab

Related studies linked through entity extraction aliases.

A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer

Status: COMPLETED
Phase: PHASE3

FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients

Status: COMPLETED
Phase: PHASE2

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

Status: TERMINATED
Phase: PHASE2

Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

Status: RECRUITING
Phase: PHASE2

Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab

Status: COMPLETED
Phase: PHASE2

Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer

Status: COMPLETED
Phase: PHASE1

The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)

Status: COMPLETED
Phase: PHASE2

A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma

Status: WITHDRAWN
Phase: PHASE3

Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC

Status: COMPLETED
Phase: PHASE2

A Trial of Ipatasertib in Combination With Atezolizumab

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors

Status: UNKNOWN
Phase: PHASE2

Combinatory ImmunoTherapy-1 (Com-IT-1) Irradiation and PD-1 Blockade in Locally Advanced / Advanced NSCLC

Status: TERMINATED
Phase: PHASE2

Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies

Status: TERMINATED
Phase: PHASE1/PHASE2

CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

Status: COMPLETED
Phase: PHASE2

A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases

Status: COMPLETED
Phase: PHASE2

Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer

Status: UNKNOWN
Phase: PHASE2

This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers

Status: TERMINATED
Phase: PHASE1

Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC

Status: UNKNOWN
Phase: PHASE2

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2